Bml-210

SKU:BHB11900136
Suppliers
StressMarq Biosciences Inc.
StressMarq Biosciences Inc.
Details Products
Overview
Click light‑blue chips for details
Bml-210 (N1-(2-aminophenyl)-N8-phenyloctanediamide) is a research-grade small-molecule inhibitor of HDAC supporting Cell Signaling and Epigenetics and Nuclear Signaling research. Supplied as a tan solid with >98% purity (CAS 537034-17-6, MW 339.4) soluble in 25 mg/ml DMSO or 10 mg/ml Ethanol; store at -20°C. For research use only.
Cas No. 537034-17-6
Molecular Formula C20H25N3O2
Purity >98% (TLC), NMR conforms
Application Notes HDAC inhibitor
Options selector
Catalog no. Size
SIH-348-5MG 5 mg
SIH-348-25MG 25 mg
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size (2) — 25 mg, 5 mg.
  • Lead time: options listed as “in stock at manufacturer” typically ship in 2-3 business days; other statuses may take longer.
  • Storage: -20ºC
  • Shipping: ships at ambient temperature.
  • Upon receipt: store at the recommended temperature as soon as possible.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Mfr No SIH-348
Activity
  • Inhibitor
Alternative Names N1-(2-aminophenyl)-N8-phenyloctanediamide
Cas No. 537034-17-6
Form Tan Solid
Molecular Weight 339.4
Product Type
  • Biochemicals
  • Small Molecules
Purity >98% (TLC), NMR conforms
Shipping Shipped Ambient
SMILES C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NC2=CC=CC=C2N
Solubility Soluble in 25 mg/ml DMSO or 10 mg/ml Ethanol
Source Synthetic
Storage -20ºC

Bml-210 is a novel non-hydroxamic acid histone deacetylase (HDAC) inhibitor that has shown promising activity in epigenetic modulation. Although its primary research applications have been in oncology, particularly in inducing growth inhibition, apoptosis, and differentiation in leukemia cell lines, its mechanism of action is increasingly relevant to neuroscience. HDAC inhibitors are being explored for their neuroprotective effects, especially in the context of neurodegenerative diseases such as Alzheimer's and Huntington's disease. By modulating chromatin structure and gene expression, Bml-210 may influence neuronal plasticity, memory formation, and neuroinflammation. Its non-hydroxamic acid structure offers a unique pharmacological profile, potentially reducing off-target effects and improving therapeutic specificity. As interest in epigenetic therapies for neurological disorders grows, Bml-210 represents a valuable tool for probing the role of HDACs in the central nervous system.

Classification: Caution- Substance not yet fully tested.

Safety Phrases:

  • S22 - Do not breathe dust
  • S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection
  • S24/25- Avoid contact with skin and eyes

Hazard Statements:

H413 – May cause long lasting harmful effects to aquatic life.

Bml-210 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-348)

Need this compound in a format that drops straight into your assay? We can tailor formulation, chemistry, and documentation so your results stay consistent across runs and re-orders.

  • Format options: solid or pre-dissolved solution (choose solvent), target concentration, aliquots, light/moisture-protected packaging
  • Chemistry options: free base/acid vs salt forms, hydrate/solvate preference, stereoisomer control (single enantiomer or racemate), close analogs
  • Add-on labels & handles: D/¹³C/¹⁵N isotopes (LC-MS/internal standards), azide/alkyne or other functional handles for conjugation
  • QC & documentation: standard COA or enhanced analytical pack (HPLC/LC-MS/NMR), chiral purity, residual solvents, water content (KF), method-specific specs
  • Scale & continuity: mg to gram scale, bulk pricing, lot reservation, repeat-order continuity

To quote quickly, tell us: compound name + CAS/structure (SMILES or mol file), intended assay context, solvent preference, salt/stereochemistry requirements, purity/QC level, and the amount (mg–g).

Can’t find the compound you’re looking for?
Send the CAS or structure and your specs. We can help source it, suggest close equivalents, or discuss custom synthesis with the right QC documentation (RUO).

1. Savickiene J., et al. (2006) Eur. J. Pharmacol. 549: 9.
2. Herman D., et al. (2006) Nature Chem. Biol. 10: 551.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today